Zobrazeno 1 - 10
of 317
pro vyhledávání: '"Armin Gerger"'
Autor:
Katja Sallinger, Michael Gruber, Christin-Therese Müller, Lilli Bonstingl, Elisabeth Pritz, Karin Pankratz, Armin Gerger, Maria Anna Smolle, Ariane Aigelsreiter, Olga Surova, Jessica Svedlund, Mats Nilsson, Thomas Kroneis, Amin El-Heliebi
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-14 (2023)
Abstract Background Opting for or against the administration of adjuvant chemotherapy in therapeutic management of stage II colon cancer remains challenging. Several studies report few survival benefits for patients treated with adjuvant therapy and
Externí odkaz:
https://doaj.org/article/d49387f319bf4f0199754c5da523007e
Autor:
Matthias Preusser, Erika Richtig, Florian Moik, Cihan Ay, Martin Pichler, Florian Posch, Armin Gerger, Lukas Koch, Thomas Bauernhofer, Thomas Winder, Dominik A Barth, Sarah Steinlechner, Marie-Christina Mayer, Amelie M Sandner, Franziska Berton, Verena Schlintl, Nikolaus John, Robert Wurm, Patrick Reimann, Christoph Wohlkönig, Philipp J Jost, Angelika Terbuch, Jakob Michael Riedl
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 12 (2023)
Background C reactive protein (CRP) kinetics have recently been suggested as predictive biomarkers for the efficacy of immune checkpoint inhibitor (ICI) therapy in selected cancer types. The aim of this study was to characterize early CRP kinetics as
Externí odkaz:
https://doaj.org/article/a40a1d9c33b346768e290b28474e9d93
Autor:
Felix Prinz, Katharina Jonas, Amar Balihodzic, Christiane Klec, Andreas Reicher, Dominik Andreas Barth, Jakob Riedl, Armin Gerger, Tobias Kiesslich, Christian Mayr, Beate Rinner, Julia Kargl, Martin Pichler
Publikováno v:
RNA Biology, Vol 19, Iss 1, Pp 1305-1315 (2022)
The microRNA-200 family has wide-ranging regulatory functions in cancer development and progression. Above all, it is strongly associated with the epithelial-to-mesenchymal transition (EMT), a process during which cells change their epithelial to a m
Externí odkaz:
https://doaj.org/article/9edcfdbbce2f49dc9ef762600d2aaea8
Autor:
Hossein Taghizadeh, Angela Djanani, Wolfgang Eisterer, Armin Gerger, Birgit Gruenberger, Thomas Gruenberger, Holger Rumpold, Lukas Weiss, Thomas Winder, Ewald Wöll, Gerald W. Prager
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Locally advanced or metastatic cholangiocarcinoma is an aggressive carcinoma with a dismal prognosis. For the first-line treatment of locally advanced or metastatic cholangiocarcinoma, cisplatin/gemcitabine has been the standard of care for more than
Externí odkaz:
https://doaj.org/article/ac2eb60400d44723bdbe5729355db3ab
Autor:
Dominik A. Barth, Stefanie Stanzer, Jasmin Spiegelberg, Thomas Bauernhofer, Gudrun Absenger, Florian Posch, Rainer Lipp, Michael Halm, Joanna Szkandera, Marija Balic, Armin Gerger, Maria A. Smolle, Georg C. Hutterer, Christiane Klec, Philipp J. Jost, Julia Kargl, Martin Stradner, Martin Pichler
Publikováno v:
Cancer Medicine, Vol 11, Iss 16, Pp 3074-3083 (2022)
Abstract Background The presence of autoantibodies in the serum of cancer patients has been associated with immune‐checkpoint inhibitor (ICI) therapy response and immune‐related adverse events (irAEs). A prospective evaluation of different autoan
Externí odkaz:
https://doaj.org/article/8914eb1a50484886b516dc8999f59708
Autor:
Dominik A. Barth, Stefanie Stanzer, Jasmin A. Spiegelberg, Thomas Bauernhofer, Gudrun Absenger, Joanna Szkandera, Armin Gerger, Maria A. Smolle, Georg C. Hutterer, Sascha A. Ahyai, Tobias Madl, Florian Posch, Jakob M. Riedl, Christiane Klec, Philipp J. Jost, Julia Kargl, Martin H. Stradner, Martin Pichler
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundImmune checkpoint inhibitors (ICIs) have revolutionized systemic anti-tumor treatments across different types of cancer. Nevertheless, predictive biomarkers regarding treatment response are not routinely established yet. Apart from T-lympho
Externí odkaz:
https://doaj.org/article/1c7e71b457324a089d3b19334f744c70
Autor:
Dominik Andreas Barth, Carina Brenner, Jakob Michael Riedl, Felix Prinz, Eva Valentina Klocker, Konstantin Schlick, Peter Kornprat, Karoline Lackner, Herbert Stöger, Michael Stotz, Armin Gerger, Martin Pichler
Publikováno v:
Cancer Medicine, Vol 9, Iss 15, Pp 5473-5479 (2020)
Abstract Background The advanced lung cancer inflammation index (ALI) was first introduced for prognosis prediction in lung cancer patients and since then evaluated in several other malignancies. However, in pancreatic cancer (PC) the ALI and its pro
Externí odkaz:
https://doaj.org/article/28b62e9a84b64f2e8f8fed8ab915e556
Autor:
Qing Zhou, Samantha O. Perakis, Peter Ulz, Sumitra Mohan, Jakob M. Riedl, Emina Talakic, Sigurd Lax, Martin Tötsch, Gerald Hoefler, Thomas Bauernhofer, Martin Pichler, Armin Gerger, Jochen B. Geigl, Ellen Heitzer, Michael R. Speicher
Publikováno v:
Genome Medicine, Vol 12, Iss 1, Pp 1-17 (2020)
Abstract Background Bevacizumab, a monoclonal antibody against soluble VEGFA, is an approved and commonly administered anti-angiogenic drug in patients with metastasized colorectal cancer (mCRC). The survival benefit of anti-VEGF therapy in mCRC pati
Externí odkaz:
https://doaj.org/article/fc254d7ec85e448b9fbac1d663e3b0b7
Autor:
Moritz Müller, Florian Posch, Dominik Kiem, Dominik Barth, Lena Horvath, Michael Stotz, Renate Schaberl-Moser, Martin Pichler, Richard Greil, Philipp J. Jost, Andreas Seeber, Arno Amann, Konstantin Schlick, Armin Gerger, Jakob M. Riedl
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: The level of evidence for palliative second-line therapy in advanced esophageal squamous cell carcinoma (aESCC) is limited. This is the first study that reports efficacy data comparing second-line therapy + active symptom control (ASC) ve
Externí odkaz:
https://doaj.org/article/051ef20ccbc94d37ab602098e3f67016
Autor:
Susanne Scheipl, Iva Brcic, Tina Moser, Stefan Fischerauer, Jakob Riedl, Marko Bergovec, Maria Smolle, Florian Posch, Armin Gerger, Martin Pichler, Herbert Stoeger, Andreas Leithner, Ellen Heitzer, Bernadette Liegl-Atzwanger, Joanna Szkandera
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: Molecular diagnosis has become an established tool in the characterisation of adult soft-tissue sarcomas (STS). FoundationOne ® Heme analyses somatic gene alterations in sarcomas via DNA and RNA-hotspot sequencing of tumour-associated ge
Externí odkaz:
https://doaj.org/article/ce9c0db0b0b848cfa33d6e6474e88316